middle.news

Algorae Pharmaceuticals Validates Enhanced AlgoraeOS v2 Drug Synergy Platform

9:03am on Friday 3rd of July, 2026 AEST Pharmaceuticals
Read Story

Algorae Pharmaceuticals Validates Enhanced AlgoraeOS v2 Drug Synergy Platform

9:03am on Friday 3rd of July, 2026 AEST
Key Points
  • Independent preclinical validation of AlgoraeOS v2 completed
  • AOS2 predicted drug synergies with 2.5 times greater accuracy than AOS1
  • Approximately 10,000 data points generated from 24 drug-CBD combos
  • Introduction of uncertainty metrics improved predictive confidence
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE